Brief: Orbimed Advisors Reports 12.0% Stake In MBX Biosciences As Of Sept 16 - SEC Filing
23/09/2024 21:47
Sept 23 (Reuters) - MBX Biosciences Inc MBX.O :
* ORBIMED ADVISORS LLC REPORTS 12.0% STAKE IN MBX
BIOSCIENCES AS
OF SEPT 16 - SEC FILING
Source text for Eikon: ID:n0000947871-24-000767
Further company coverage: MBX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MBX Biosciences
See all newsU.S. RESEARCH ROUNDUP-Health Catalyst, Nektar Therapeutics, TIC Solutions
MBX Biosciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: MBX Biosciences Announces Executive Leadership Transition To Support The Company’S Next Phase Of Growth
MBX Biosciences falls after executive shakeup
U.S. STOCKS ON THE MOVE-SpaceX, Tesla, Woodside Energy Group